Top of the Class: Why MiYOSMART iQ Belongs on Every Back-to-School Checklist

Back-to-school season brings a familiar surge of pediatric eye exams; and with it, a familiar missed opportunity. As parents bring children in with complaints about the board or squinting through homework, the default response has long been to hand them a single-vision prescription and send them on their way. But as childhood myopia rates continue to climb, that approach is no longer enough. Myopia management isn't an add-on conversation to have if there's time: It's a clinical recommendation that belongs in every exam where progressive myopia is a finding. This season, the tools and the data are on your side.

Back-to-School Eye Care: Looking Beyond Single-Vision Correction

Every September, practices across Canada see the same thing: A child who can't see the board and a parent who wants a quick fix. Single-vision correction solves a symptom of myopia—blurry vision—but it doesn't address what's actually happening inside the eye.

That's where providers have a responsibility that goes beyond the refraction. Most parents don't know that myopia is a progressive condition that can worsen significantly during childhood. The average person walks into your office not knowing that childhood myopia is a progressive condition. They assume their child's prescription is a static fact of life, something to be corrected and managed with updated lenses each year. What they don't know is that the eye is actively and physically changing and that the window to intervene is open right now, in childhood, when that progression is happening fastest.

The shift to make this back-to-school season is framing myopia management not as an elective upgrade, but as a non-negotiable medical recommendation grounded in clinical data. When the data supports early intervention, that recommendation belongs in the conversation.

The Power of Early Intervention

For years, the clinical approach to pediatric myopia often involved a "wait and see" mindset: monitor the prescription, update the lenses, and intervene when things got bad enough. That approach is now outdated.

For the first time, MiYOSMART iQ, a D.I.M.S. (Defocus Incorporated Multiple Segments) technology-based spectacle lens has proven it can control myopia in children as young as 4¹—and that changes the calculus on when to intervene.

Early-onset myopia progresses rapidly, and initiating effective myopia control early in life may reduce cumulative progression and lower the risk of developing high myopia and associated sight-threatening diseases later in life.

The evidence is clear: waiting for a prescription to worsen significantly before intervening is no longer a defensible clinical position. The younger the patient, the higher the stakes—and with MiYOSMART iQ, you now have the clinical evidence to act earlier than ever before.

Anchoring the Recommendation in Clinical Data

When a parent hesitates (whether over cost, necessity, or unfamiliarity) you need precise, data-backed language to respond with confidence. Here's what the research supports:

In a randomized controlled trial including 196 children aged 4 to 12 years, those wearing MiYOSMART iQ spectacle lenses showed no myopia progression on average at 12 months. Axial elongation was reported to be below or comparable to that of children without refractive errors.¹ ²

For children aged 7 to 12 years, MiYOSMART iQ demonstrated myopia control efficacy of more than 100% in spherical equivalent refractive error and 94% in axial length over 12 months. In practical terms, MiYOSMART iQ nearly stopped the physical growth of the eye that drives myopia progression in this age group.¹ ² ³

Researchers described these findings as the highest myopia-control efficacy reported to date in children wearing D.I.M.S. technology-based spectacle lenses. You can find more in-depth detail on the 12-month data here.

Talking Points for Patient Conversations: Handling Common Parent Objections

Use this quick-reference Q&A to navigate the most common hesitations you'll hear from parents this season.

“I have terrible eyesight and my spouse wears thick glasses. Isn't it just bad genetics? Can we actually stop it from getting worse in our child?"
- Suggested Response: Acknowledge that family history matters, then pivot.
- Example: “Family history does increase a child's risk. That said, a high prescription is no longer inevitable. Technology like MiYOSMART iQ can actively change that trajectory. So the question for us isn't whether genetics play a role, it's whether we act on what we know now.”
“Can we just wait and see if it gets worse next year/in a year or two?"
- Suggested Response: Validate the instinct to take a cautious approach, then explain why waiting carries its own risks.
- Example: "I completely understand the impulse to wait and see. The challenge is that myopia in children can progress very quickly, and treatments like MiYOSMART iQ don't reverse progression that's already happened—they prevent it from happening in the first place. Allowing the eye to keep elongating unchecked also increases the risk of permanent ocular health complications later in life. The safest path forward is to act early, while we can make the most impact."
“My child's prescription is getting worse, but can't they just get LASIK surgery when they grow up to fix it?"
- Suggested Response: Clarify what LASIK does and doesn't address, without dismissing the idea entirely.
- Example: "LASIK is a great option for a lot of people, and it may well be something your child considers down the road. It reshapes the surface of the eye to reduce the need for glasses. It can't reverse the physical stretching and lengthening of the eyeball itself, since that structural change is permanent. Not every patient is a LASIK candidate, and lower myopes are generally better candidates, with a lower risk of complications or regression. Managing myopia now can reduce the risk of irreversible ocular disease later in life that LASIK cannot correct."
“I heard that if you give a child glasses, their eyes become weaker and the condition keeps getting worse. Can we wait, or use a slightly weaker prescription to make the eye muscles work harder to stop their eyes from getting worse?"
- Suggested Response: Address the myth directly before offering the evidence.
- Example: "That's actually a question we hear fairly often, and it's worth clearing up. That idea has been around for a long time, but clinical data now shows the opposite: Under-correcting a child's vision actually accelerates eye elongation and makes myopia progress faster. Full correction, paired with a proven myopia management approach like MiYOSMART iQ, is where the evidence points."
“Are these glasses going to look weird? I can see faint little circles or dots in the lens when the light hits it. Won't that make my kid's vision blurry or get them teased at school?"
- Suggested Response: Acknowledge the concern warmly before walking them through how the lens actually works.
- Example: "That's such a common concern, and I'm glad you brought it up. Those faint little circles are actually how the lens works. They create a gentle signal that helps tell the eye to slow down its growth. The good news is that your child won't notice them in everyday life. Our brains are incredible at filtering out visual information that's not important—just like your nose. Your brain always knows it's there, but because it's not a concern, it simply tunes it out. Your child looks through the clear center of the lens for crisp vision, while the treatment segments sit in their peripheral vision. In fact, many children don't notice them at all, and those who do usually adapt very quickly. And to everyone else, they look just like a regular pair of glasses."

The back-to-school season is one of the highest-volume windows of the year for pediatric eye care. It’s also one of the most important opportunities to intervene early in a child's myopia trajectory. MiYOSMART iQ offers a myopia management solution backed by clinical data, with demonstrated efficacy across a wider age range than ever before.

As you prepare for the fall rush, consider making myopia management a standard part of every conversation, rather than an afterthought.

For more information about MiYOSMART iQ, please contact your local HOYA Vision Care representative.